Remission as an Emerging Therapeutic Target in Type 2 Diabetes in the Era of New Glucose-Lowering Agents: Benefits, Challenges, and Treatment Approaches

Type 2 diabetes mellitus (T2DM) is a progressive disease with a growing prevalence, associated with an increased risk of complications. The introduction of new classes of antidiabetic drugs into clinical practice has dramatically changed the landscape of diabetes therapy. However, despite the progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasdeki, Dimitra, Koufakis, Theocharis, Tsamos, Georgios, Busetto, Luca, Zebekakis, Pantelis, Kotsa, Kalliopi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695991/
https://www.ncbi.nlm.nih.gov/pubmed/36432488
http://dx.doi.org/10.3390/nu14224801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695991/
https://www.ncbi.nlm.nih.gov/pubmed/36432488
http://dx.doi.org/10.3390/nu14224801

Ejemplares similares